Symbols / MEDS
MEDS Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- Remedy Meds Acquires Thirty Madison in All-Stock Deal Valued at over $500M - HLTH Mon, 08 Sep 2025 07
- Lilly Shares Have Tripled on Weight-Loss Drugs. Why the Stock Looks Cheap. - Barron's Fri, 19 Dec 2025 08
- Exclusive: Remedy Meds to acquire Thirty Madison - Axios Wed, 03 Sep 2025 07
- Weight-Loss Drugs Are Hot. Only One Stock Is. - Investor's Business Daily Fri, 07 Nov 2025 08
- GLP-1 weight loss meds lead to changes in consumer food demand - study - Seeking Alpha Fri, 26 Dec 2025 08
- M&A: Remedy Meds Acquires Thirty Madison in All-Stock Deal Valued at over $500M - - HIT Consultant Fri, 05 Sep 2025 07
- Weight loss drugs for cats? Company launches clinical trial of GLP-1 implants in cats - Good Morning America ue, 02 Dec 2025 08
- Remedy Meds Acquires Thirty Madison in $500M All-Stock Deal - Femtech Insider hu, 04 Sep 2025 07
- Meds to get cheaper by March end, retailers worry about existing stock - The Times of India ue, 03 Feb 2026 08
- Real-time GP meds stock checks to reduce abuse in pharmacies - Chemist+Druggist Wed, 11 Feb 2026 08
- 7 Best Costco OTC Meds To Stock Up On This Month - Eat This Not That Sun, 22 Jun 2025 07
- Merck: Game-Changing Oncology Drugs Power Stock Surge (NYSE:MRK) - Seeking Alpha Fri, 26 Sep 2025 07
- More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma - KFF Health News ue, 03 Oct 2023 07
- TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Stock Titan Fri, 26 Jul 2024 07
- McDonald's Stock Bitten By Big Downgrade Over Weight-Loss Drugs - Investor's Business Daily ue, 10 Jun 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MEDS
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|